Canals-Lambarri M, Canals-Cifuentes A, Barros-Rocco A, Barros-Nelson P, Mahave-Caceres M, Salman-Boghikian P

Idioma: Ingles.
Referencias bibliográficas: 20
Paginas: 182-190
Archivo PDF: 224.63 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Suzuki C, Jacobson H, Hatschek T, et al. Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics. 2008;28:329-44.

2. World Health Organization. WHO handbook for reporting results of cancer treatment. Available at: http://whqlibdoc.who. int/publications/9241700483.pdf.

3. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment on Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-16.

4. Therasse P, Eisenhauer EA, Verweij J. RECIST revisited: A review of validation studies on tumour assessment. Eur J Cancer. 2006;42:1031-9.

5. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-47.

6. Van Persijn Van Meerten EL, Gelderblom H, Bloem JL. RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline. Eur Radiol. 2010;20:1456-67.

7. Canals M, Fernández M, Barros A, Barros P, Salman P, Mahave M. Buscando una curva general de respuesta a la quimioterapia basado en la evaluación radiológica con criterio RECIST. Rev Chil Radiol. 2009;15:1-4.

8. James K, Eisenhauer E, Christian M, et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst. 1999;91:523-8.

9. Dacchman AH, MacEneaney PM, Adedipe A, Carlin M, Schumm LP. Tumor size on computed tomography scans: is one measurement enough? Cancer. 2001:91:555-60.

10. Warren KE, Patronas N, Aikin AA, Albert PS, Balis FM. Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors. J Natl Cancer Inst. 2001;93:1401-5.

11. Mazumdar M, Smith A, Schwartz LH. A statistical simulation study finds discordance between WHO criteria and RECIST guideline. J Clin Epidemiol. 2004;57:358-65.

12. Zacharia TT, Saini S, Halpern EF, Sumner JE. CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure. Am J Roentgenol. 2006;186:1067-70.

13. Hillman SL, Ming-Wen A, O’Connell MJ, et al. Evaluation of the optimal number of lesions needed for tumor evaluation using the Response Evaluation Criteria in Solid Tumors: A North Central Cancer Treatment. J Clin Oncol. 2009;27:3205-10.

14. Gonen M, Schwartz L, Ford R. Evaluation of number of target lesions to analyze in time to progression by RECIST. ASCO Annual Meeting Proceedings (Post-Meeting Edition). J Clin Oncol. 2007;25:6549.

15. Mazumdar M, Smith A, Debroy PP, Schwartz LH. A theoretical approach to choosing the minimum number of multiple tumors required for assessing treatment response. J Clin Epidemiol. 2005;58:150-3.

16. Suzuki C, Blomquist L, Sundin A, et al. The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy. Ann Oncol. 2012;23:948-54.

17. Altman DG, Bland JM. Measurement in Medicine: The analysis of method comparison studies. The Statistician 1983; 32: 307-317.

18. Rencher AC. Methods in Multivariate Analysis, 2nd Ed. New York: Wiley Interscience. J Wiley & Sons, Inc., 2002.

19. Bushong SC. Radiobiología molecular y celular. In Bushong SC, editor. Manual de Radiología para Técnicos. Madrid: Esxta Ed. Harcourt Brace, 1998:449-63.

20. Moskowitz C, Jia X, Schwartz L, Gonen M. A simulation study to evaluate the impact of the number of lesions measured on response assessment. Eur J Cancer. 2009;45:300-10.